FDG PET/CT in Lung Cancer Staging

Clinical trial NCT02738398 · COMPLETED

Trial details

NCT number: NCT02738398
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer (NSCLC)

Start date: 2016-04-01
Primary completion: 2026-01-27
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.